Xperiome in numbers
The Raremark community is made up of over 11,000 active patients and caregivers worldwide (as of July 31, 2020). The Xperiome platform powers this community of research-activated patients and caregivers, enabling partnerships with pharmaceutical companies working in respiratory disorders, hematology, metabolism, gastrointestinal disease, and immunology. We will continue to expand into additional therapeutic areas over time.
Download Xperiome in numbers to learn more about our global reach.
Sign up for updates
If you’d like to receive Xperiome updates directly in your inbox, just click ‘Sign up’ and fill in your details.